Published in Brain Res on June 12, 1999
Ginseng ginsenoside pharmacology in the nervous system: involvement in the regulation of ion channels and receptors. Front Physiol (2014) 0.91
A-type K+ currents in intralaminar thalamocortical relay neurons. Pflugers Arch (2011) 0.80
Dynamics of aminopyridine block of potassium channels in squid axon membrane. J Gen Physiol (1976) 4.36
Kinetic analysis of pancuronium interaction with sodium channels in squid axon membranes. J Gen Physiol (1977) 3.95
Interactions of aminopyridines with potassium channels of squid axon membranes. Biophys J (1976) 3.69
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2007) 3.12
Voltage-dependent calcium block of normal and tetramethrin-modified single sodium channels. Biophys J (1984) 2.60
Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology (2011) 2.47
Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology. Neurology (2010) 2.29
The cost of delaying treatment in multiple sclerosis: what is lost is not regained. Neurology (2001) 2.27
Immobilisation of gating charge by a substance that simulates inactivation. Nature (1978) 2.19
Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J Cell Biol (2000) 2.11
Sodium inactivation mechanism modulates QX-314 block of sodium channels in squid axons. Biophys J (1978) 1.97
Na channel activation gate modulates slow recovery from use-dependent block by local anesthetics in squid giant axons. Biophys J (1985) 1.58
Interactions of monovalent cations with sodium channels in squid axon. I. Modification of physiological inactivation gating. J Gen Physiol (1985) 1.51
Endplate channel block by guanidine derivatives. J Gen Physiol (1981) 1.46
Sodium current kinetics in cat atrial myocytes. J Physiol (1987) 1.36
Prognosis of ocular myasthenia. Ann Neurol (1983) 1.35
Assembly properties of dominant and recessive mutations in the small mouse neurofilament (NF-L) subunit. J Cell Biol (1990) 1.34
Interaction of n-alkylguanidines with the sodium channels of squid axon membrane. J Gen Physiol (1980) 1.34
Evidence for two components of sodium channel block by lidocaine in isolated cardiac myocytes. Circ Res (1988) 1.30
A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein. J Cell Biol (1999) 1.28
Dynamics of 9-aminoacridine block of sodium channels in squid axons. J Gen Physiol (1979) 1.27
Differential actions of insecticides on target sites: basis for selective toxicity. Hum Exp Toxicol (2007) 1.23
Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells. J Pharmacol Exp Ther (1984) 1.20
Kinetics of 9-aminoacridine block of single Na channels. J Gen Physiol (1984) 1.19
A pharmacological approach to the structure of the Na channel in squid axon. Prog Clin Biol Res (1982) 1.17
Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels. J Pharmacol Exp Ther (1997) 1.15
Mechanism of action of quinidine on squid axon membranes. J Pharmacol Exp Ther (1976) 1.15
Modulation of aminopyridine block of potassium currents in squid axon. Biophys J (1986) 1.13
Penicillamine-induced myasthenia gravis: effects of penicillamine on acetylcholine receptor. Neurology (1982) 1.13
Characterization of the replication terminus of the Bacillus subtilis chromosome. J Gen Microbiol (1984) 1.12
A quantitative description of QX222 blockade of sodium channels in squid axons. Biophys J (1986) 1.12
General anesthetics modulate GABA receptor channel complex in rat dorsal root ganglion neurons. FASEB J (1989) 1.10
Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N141I). J Cell Biol (1997) 1.09
Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons. J Pharmacol Exp Ther (1997) 1.09
Interactions of permeant cations with sodium channels of squid axon membranes. Biophys J (1985) 1.08
Voltage-dependent removal of sodium inactivation by N-bromoacetamide and pronase. Biophys J (1985) 1.07
Dual action of n-alcohols on neuronal nicotinic acetylcholine receptors. Mol Pharmacol (2001) 1.05
Batrachotoxin uncouples gating charge immobilization from fast Na inactivation in squid giant axons. Biophys J (1988) 1.04
The role of sequences unique to nuclear intermediate filaments in the targeting and assembly of human lamin B: evidence for lack of interaction of lamin B with its putative receptor. J Cell Sci (1998) 1.04
BTX modification of Na channels in squid axons. I. State dependence of BTX action. J Gen Physiol (1991) 1.04
Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles. Ann N Y Acad Sci (1976) 1.04
The role of cell cycle-mediated events in Alzheimer's disease. Int J Exp Pathol (1999) 1.02
Primary structure of an alpha-tubulin gene of Physarum polycephalum. J Mol Biol (1987) 1.02
Interactions of monovalent cations with sodium channels in squid axon. II. Modification of pharmacological inactivation gating. J Gen Physiol (1985) 1.00
Modulation of neuronal nicotinic acetylcholine receptors by halothane in rat cortical neurons. Mol Pharmacol (2001) 1.00
The rodent malaria parasite Plasmodium yoelii lacks both types 1 and 2 T-independent antigens. J Immunol (1982) 0.99
A preliminary trial of poly(I,C)-LC in multiple sclerosis. J Biol Response Mod (1985) 0.99
Use- and voltage-dependent block of the sodium channel by saxitoxin. Ann N Y Acad Sci (1986) 0.97
Molecular and structural basis of resting and use-dependent block of sodium current defined using disopyramide analogues. Biophys J (1987) 0.96
Amiodarone-induced block of sodium current in isolated cardiac cells. J Pharmacol Exp Ther (1987) 0.96
Involvement of neurofilaments in the radial growth of axons. J Cell Sci Suppl (1991) 0.95
Removal of sodium inactivation and block of sodium channels by chloramine-T in crayfish and squid giant axons. Biophys J (1987) 0.91
Determination of the active form of phenytoin. J Pharmacol Exp Ther (1984) 0.91
Fipronil modulation of gamma-aminobutyric acid(A) receptors in rat dorsal root ganglion neurons. J Pharmacol Exp Ther (2001) 0.91
Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases. Ann Neurol (1983) 0.91
Identification and characterization of a novel (115 kDa) neurofilament-associated kinase. J Neurosci (1994) 0.89
All or none block of single Na+ channels by tetrodotoxin. Neurosci Lett (1985) 0.88
Presenilin overexpression arrests cells in the G1 phase of the cell cycle. Arrest potentiated by the Alzheimer's disease PS2(N141I)mutant. Am J Pathol (1999) 0.88
Interaction of spin-labeled local anesthetics with the sodium channel of squid axon membranes. J Membr Biol (1982) 0.87
Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration. Neurology (1996) 0.86
QX-314 restores gating charge immobilization abolished by chloramine-T treatment in squid giant axons. Biophys J (1989) 0.86
alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease. J Neuropathol Exp Neurol (1996) 0.86
Glatiramer acetate blocks the activation of THP-1 cells by interferon-gamma. Eur J Pharmacol (1998) 0.86
Modeling pathogenesis of Huntington's disease with inducible neuroprogenitor cells. Cell Mol Neurobiol (2011) 0.84
Neurofilament phosphorylation is modulated by myelination. J Neurosci Res (1996) 0.83
Potent modulation of neuronal nicotinic acetylcholine receptor-channel by ethanol. Neurosci Lett (1996) 0.83
Clinical trials of interferons in multiple sclerosis. What have we learned? J Neuroimmunol (1993) 0.83
Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. Neurobiol Aging (2001) 0.82
Ion channel modulation as the basis for general anesthesia. Toxicol Lett (1998) 0.82
Basis of variable sensitivities of GABA(A) receptors to ethanol. Alcohol Clin Exp Res (2000) 0.81
Differential block of two types of sodium channels by anticonvulsants. Neuroreport (1996) 0.81
Ion permeation and selectivity of squid axon sodium channels modified by tetramethrin. Brain Res (1986) 0.80
Induction of RANTES chemokine expression in human astrocytic cells is dependent upon activation of NF-kappaB transcription factor. Int J Mol Med (2001) 0.80
Epidural metastasis by Wilms' tumor. Am J Dis Child (1981) 0.79
Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cells. Brain Res Mol Brain Res (2001) 0.79
A comparison of interferon responses to poly ICLC in males and females. J Interferon Res (1985) 0.79
Effects of IFN-beta on human cerebral blood flow distribution. J Interferon Cytokine Res (1998) 0.79
Ion channels as targets for neuroprotective agents. Ann N Y Acad Sci (1997) 0.78
Modulation of interferon gamma induced increases in cathepsin B in THP-1 cells by adrenergic agonists and antagonists. Cell Biol Int (1998) 0.78
Evidence that alpha-dihydrograyanotoxin II does not bind to the sodium gate. J Membr Biol (1975) 0.78
Preliminary trial of poly ICLC in chronic progressive multiple sclerosis. Neurology (1986) 0.78
Production of monoclonal antibodies against neurofilament-associated proteins: demonstration of association with neurofilaments by a coimmunoprecipitation method. J Neurochem (1995) 0.78
Endotoxin induces increased intracellular cathepsin B activity in THP-1 cells. Immunopharmacol Immunotoxicol (1997) 0.78
Agonist and potentiation actions of n-octanol on gamma-aminobutyric acid type A receptors. Mol Pharmacol (1999) 0.78
Effect of propranolol and IFN-beta on the induction of MHC class II expression and cytokine production by IFN-gamma IN THP-1 human monocytic cells. Immunopharmacol Immunotoxicol (1998) 0.77
On the mechanisms of genotoxicity and metabolism of quercetin. Mutagenesis (1994) 0.77
Structure and expression of an alpha-tubulin gene of Physarum polycephalum. Eur J Biochem (1989) 0.77
Halothane acts as a partial agonist of the alpha6 beta2 gamma2S GABA(A)receptor. FASEB J (1996) 0.77
Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury? Neurology (1999) 0.77
Modulation of tetrodotoxin-resistant sodium channels by dihydropyrazole insecticide RH-3421 in rat dorsal root ganglion neurons. Neurotoxicology (2001) 0.77
Glutathione S-transferase mu polymorphism and susceptibility to lung cancer in the Portuguese population. Teratog Carcinog Mutagen (1996) 0.77
Effects of the oxadiazine insecticide indoxacarb, DPX-MP062, on neuronal nicotinic acetylcholine receptors in mammalian neurons. Neurotoxicology (1999) 0.77
Glatiramer acetate inhibition of tumor necrosis factor-alpha-induced RANTES expression and release from U-251 MG human astrocytic cells. J Neurochem (2001) 0.77
Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcription. Neurochem Res (2001) 0.77
Post-stroke dementia. Nootropic drug modulation of neuronal nicotinic acetylcholine receptors. Ann N Y Acad Sci (2001) 0.77
Mechanisms underlying the synergistic effect of Th1 cytokines on RANTES chemokine production by human glial cells. Int J Mol Med (2001) 0.77
Modulation of GABA receptor-channel complex by alcohols and general anesthetics. Adv Biochem Psychopharmacol (1992) 0.76
Nootropic drug modulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons. Mol Pharmacol (2001) 0.76
A cdc2-like kinase distinct from cdk5 is associated with neurofilaments. J Cell Sci (1996) 0.76
A new series of trpE vectors that enable high expression of nonfusion proteins in bacteria. Protein Expr Purif (1992) 0.76